Dasatinib Vivanta 20 mg filmomhulde tabletten
As listed in the register: Dasatinib Vivanta 20 mg filmomhulde tabletten
20 mg · filmomhulde tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Dasatinib
- Made by
- Vivanta Generics s.r.o.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States16 matching products
Bulgaria2 matching products
European UnionNo exact match for this strength and form
Spain6 matching products
- SPRYCEL 20 mg · comprimido recubierto con película2 makers
- DASATINIB ACCORD 20 mg · comprimido recubierto con película
- DASATINIB ACCORD HEALTHCARE 20 mg · comprimido recubierto con película
- DASATINIB TEVA 20 mg · comprimido recubierto con película
- DASATINIB VIATRIS 20 mg · comprimido recubierto con película
France7 matching products
- DASATINIB BIOGARAN 20 mg · comprimé pelliculé
- DASATINIB EG 20 mg · comprimé pelliculé
- DASATINIB KRKA 20 mg · comprimé pelliculé
- DASATINIB SANDOZ 20 mg · comprimé pelliculé
- DASATINIB VIATRIS 20 mg · comprimé pelliculé
- DASATINIB VIVANTA 20 mg · comprimé pelliculé
- DASATINIB ZENTIVA 20 mg · comprimé pelliculé
Canada6 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Vivanta Generics s.r.o. |
|---|---|
| Active substance | Dasatinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg |
| Form | filmomhulde tablet |
| Classification | L01EA02 · Cancer treatments and immune-system medicines |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| RVG | 123308 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.